Myriad Genetics (MYGN) EBT Margin (2009 - 2026)
Myriad Genetics (MYGN) reported EBT Margin of 17.02% for Q1 2026, down 201.0% year-over-year from 16.85% in Q1 2025, and down 301.12% quarter-over-quarter from 4.24% in Q4 2025.
Myriad Genetics (MYGN) EBT Margin (2009 - 2026) Analysis & Trends
Myriad Genetics (MYGN) has 18 years of EBT Margin data on file, last reported at 17.02% in Q1 2026.
- EBT Margin for Q1 2026 came in at 17.02%, down 201.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 48.23% (down 3296.0% YoY), and the FY2025 annual result was 47.92%, down 3318.0% from the prior year.
- EBT Margin slipped to 17.02% in Q1 2026 per MYGN's latest filing, from 4.24% in the prior quarter.
- Over five years, EBT Margin peaked at 4.24% in Q4 2025 and troughed at 155.14% in Q2 2025.
- A 5-year average of 28.66% and a median of 17.02% in 2026 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2024 and 2025: EBT Margin surged 4568 bps in 2024, then sank 13755 bps in 2025.
- A 5-year view of EBT Margin shows it stood at 29.3% in 2022, then soared by 44 bps to 16.43% in 2023, then fell by 13 bps to 18.57% in 2024, then surged by 77 bps to 4.24% in 2025, then sank by 301 bps to 17.02% in 2026.
- Business Quant data shows MYGN's EBT Margin at 17.02% in Q1 2026, 4.24% in Q4 2025, and 12.74% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -6.95% |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 15.76% |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 20.75% |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 31.16% |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 22.23% |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 7.90% |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -12.17% |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 14.39% |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 22.14% |
| 10 | Myriad Genetics | 411.34 Mn | 286.94 Mn | 137.60 Mn | -17.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.02% |
| Dec 31, 2025 | -4.24% |
| Sep 30, 2025 | -12.74% |
| Jun 30, 2025 | -155.14% |
| Mar 31, 2025 | -15.01% |
| Dec 31, 2024 | -18.57% |
| Sep 30, 2024 | -9.94% |
| Jun 30, 2024 | -17.59% |
| Mar 31, 2024 | -12.81% |
| Dec 31, 2023 | -16.43% |
| Sep 30, 2023 | -31.89% |
| Jun 30, 2023 | -63.27% |
| Mar 31, 2023 | -29.03% |
| Dec 31, 2022 | -29.30% |
| Sep 30, 2022 | -28.26% |
| Jun 30, 2022 | -9.98% |
| Mar 31, 2022 | -16.01% |
| Dec 31, 2021 | -27.05% |
| Sep 30, 2021 | 23.79% |
| Jun 30, 2021 | -2.01% |